Osteoarthritis Treatment Options

There is no cure for osteoarthritis (OA), but there are treatments that can help you manage and live with the condition.² The goal of treatment is to decrease pain, maintain or improve joint movement, and limit the loss of joint function so you can enjoy an active life.² No treatment works for everybody, so be sure to discuss all the options with your doctor before starting any treatment.

According to the American College of Rheumatology (ACR), drug therapy for pain management of OA is most effective when combined with non-drug treatment strategies.² In fact, nonpharmacologic measures to manage OA pain should be maintained throughout your treatment.²

By following a stepped care treatment plan – starting with a conservative approach of simple pain medications (analgesic treatments) and moving towards joint replacement surgery as a last step – you can receive suitable treatment during each stage of your condition.^3–6 Consider which stage your condition is, and discuss a treatment plan with your physician.

Summary of Indications for Use
DUROLANE (3 mL): Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in the EU for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

DUROLANE SJ (1 mL): Symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes.

Both DUROLANE and DUROLANE SJ are also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

There are no known contraindications.

You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children.

Risks can include transient pain, swelling and/or stiffness at the injection site.

Full prescribing information can be found in Product Labeling.

DUROLANE, Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC. NASHA is a registered trademark of Nestlé Skin Health S.A.

© 2019 Bioventus LLC.

^{*First introduced in the European Union in 2001.}

To learn more about DUROLANE or for contact information, please select your location to continue.

Cookie Law

Our website uses cookies, some of which are essential for this site to operate correctly and have already been set. For more information on managing, blocking or deleting cookies within your browser please refer to the references within our Privacy Policy. By using our site you accept the terms of our Privacy policy.

Settings